Page last updated: 2024-08-20

yohimbine and bromodeoxyuridine

yohimbine has been researched along with bromodeoxyuridine in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bartlett, P; Fernandes, K; Hein, L; Jha, S; Jhaveri, D; Ladiwala, U; Marathe, SV; Muthig, V; Rommelfanger, K; Vadodaria, KC; Vaidya, VA; Weinshenker, D; Yanpallewar, SU	1

Other Studies

1 other study(ies) available for yohimbine and bromodeoxyuridine

Article	Year
Alpha2-adrenoceptor blockade accelerates the neurogenic, neurotrophic, and behavioral effects of chronic antidepressant treatment. The Journal of neuroscience : the official journal of the Society for Neuroscience, 2010, Jan-20, Volume: 30, Issue:3 Topics: Adrenergic alpha-2 Receptor Antagonists; Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Adrenergic beta-Agonists; Analysis of Variance; Animals; Animals, Newborn; Antidepressive Agents; Antiparkinson Agents; Ascorbic Acid; Behavior, Animal; Brain-Derived Neurotrophic Factor; Bromodeoxyuridine; Cells, Cultured; Dopamine beta-Hydroxylase; Doublecortin Domain Proteins; Droxidopa; Drug Administration Schedule; Drug Interactions; Embryo, Mammalian; Female; Gene Expression Regulation, Developmental; Hippocampus; Imipramine; In Vitro Techniques; Isoproterenol; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Microtubule-Associated Proteins; Nerve Tissue Proteins; Neurogenesis; Neuropeptides; Phenylephrine; Pregnancy; Prenatal Exposure Delayed Effects; Proliferating Cell Nuclear Antigen; Rats; Rats, Wistar; Reaction Time; Receptors, Adrenergic, alpha-2; Stem Cells; Yohimbine	2010

Article

Year

Alpha2-adrenoceptor blockade accelerates the neurogenic, neurotrophic, and behavioral effects of chronic antidepressant treatment.

The Journal of neuroscience : the official journal of the Society for Neuroscience, 2010, Jan-20, Volume: 30, Issue:3

Topics: Adrenergic alpha-2 Receptor Antagonists; Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Adrenergic beta-Agonists; Analysis of Variance; Animals; Animals, Newborn; Antidepressive Agents; Antiparkinson Agents; Ascorbic Acid; Behavior, Animal; Brain-Derived Neurotrophic Factor; Bromodeoxyuridine; Cells, Cultured; Dopamine beta-Hydroxylase; Doublecortin Domain Proteins; Droxidopa; Drug Administration Schedule; Drug Interactions; Embryo, Mammalian; Female; Gene Expression Regulation, Developmental; Hippocampus; Imipramine; In Vitro Techniques; Isoproterenol; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Microtubule-Associated Proteins; Nerve Tissue Proteins; Neurogenesis; Neuropeptides; Phenylephrine; Pregnancy; Prenatal Exposure Delayed Effects; Proliferating Cell Nuclear Antigen; Rats; Rats, Wistar; Reaction Time; Receptors, Adrenergic, alpha-2; Stem Cells; Yohimbine

2010